The Clinical Importance of the Metabolite Equol—A Clue to the Effectiveness of Soy and Its Isoflavones

Cassidy, 1996, Physiological effects of phyto-oestrogens in relation to cancer and other human health risks, Proc. Nutr. Soc, 55, 399, 10.1079/PNS19960038

Barnes, 1998, Evolution of the health benefits of soy isoflavones, Proc. Soc. Exp. Biol. Med, 217, 386, 10.3181/00379727-217-44249

Tham, 1998, Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence, J. Clin. Endocrinol. Metab, 83, 2223

Setchell, 1998, Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones, Am. J. Clin. Nutr, 68, 1333S, 10.1093/ajcn/68.6.1333S

Food and Drug Administration (1999) Food labeling, health claims, soy protein, and coronary heart disease. Fed. Regist. 57:699–733.

Setchell, 1984, Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease, Am. J. Clin. Nutr, 40, 569, 10.1093/ajcn/40.3.569

(2002) Soy consumption and chronic disease. In: 4th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, J. Nutr. 132:545–619

Axelson, 1984, Soya—a dietary source of the non-steroidal oestrogen equol in man and animals, J. Endocrinol, 102, 49, 10.1677/joe.0.1020049

Axelson, 1982, The identification of the weak oestrogen equol [7-hydroxy-3-(4′- hydroxyphenyl) chroman] in human urine, Biochem. J, 201, 353, 10.1042/bj2010353

Marrian, 1932, Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares urine, Biochem. J, 26, 1227, 10.1042/bj0261227

Marrian, 1935, CXC, The constitution of equol, Biochem. J, 24, 1586, 10.1042/bj0291586

Anderson, 1939, The identification of equol as 7-hydroxy-3-(4′-hydroxyphenyl) chroman, and the synthesis of racemic equol methyl ether, J. Biol. Chem, 127, 649, 10.1016/S0021-9258(18)73770-8

Bennetts, 1946, A specific breeding problem of sheep on subterranean clover pastures in Western Australia, Aust. J. Agric. Res, 22, 131

Pope, 1954, The importance of pasture plant oestrogens in the reproduction and lactation of grazing animals, Dairy Sci. Abstr, 16, 334

Lindsay, 1970, The metabolism of phyto-oestrogens in sheep, Aust. Vet. J, 46, 219, 10.1111/j.1751-0813.1970.tb02009.x

Lundh, 1995, Metabolism of estrogenic isoflavones in domestic animals, Proc. Soc. Exp. Biol. Med, 208, 33, 10.3181/00379727-208-43828

Common, 1961, Identification of equol in the urine of the domestic fowl, Biochim. Biophys. Acta, 53, 403, 10.1016/0006-3002(61)90452-8

Chang, 1974, Excretion of radioactive daidzein and equol as monosulfates and disulfates in the urine of the laying hen, Can. J. Biochem, 53, 223, 10.1139/o75-031

Klyne, 1957, Steroids and other lipids of pregnant goat's urine, Biochem. J, 66, 92, 10.1042/bj0660092

Klyne, 1959, Steroids and other lipids of pregnant cows' urine, J. Endocrinol, 18, 32, 10.1677/joe.0.0180032

Shutt, 1968, The significance of equol in relation to the oestrogenic responses in sheep ingesting clover with a high formononetin content, Aust. J. Agric. Res, 19, 545, 10.1071/AR9680545

Shutt, 1970, Quantitative aspects of phytoestrogen metabolism in sheep fed on subterranean clover (Trifolium subterraneum cultivar clare) or red clover (Trifolium pratense), Aust. J. Agric. Res, 21, 713, 10.1071/AR9700713

Setchell, 2000, Soy and other legumes: bean around a long time but are they the “Superfood” of the millennium and what are the safety issues for their constituent phytoestrogens, Asia Pac. J. Clin. Nutr, 9, S13, 10.1046/j.1440-6047.2000.009SS13.x

Setchell, 2001, Soy isoflavones—benefits and risks from nature's selective estrogen receptor modulators, J. Am. Coll. Nutr, 20, 354S, 10.1080/07315724.2001.10719168

Nagata, 1998, Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women, J. Nutr, 128, 209, 10.1093/jn/128.2.209

Wakai, 1999, Dietary intake and sources of isoflavones among Japanese, Nutr. Cancer, 33, 139, 10.1207/S15327914NC330204

Chen, 1999, Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai, Nutr. Cancer, 33, 82, 10.1080/01635589909514752

Drane, 1975, The chance discovery of oestrogenic activity in laboratory rat cake, Food Cosmet. Toxicol, 13, 491, 10.1016/S0015-6264(75)80216-1

Thigpen, 1999, Phytoestrogen content of purified, open- and closed-formula laboratory animal diets, Lab. Anim. Sci, 49, 530

Brown, 2001, Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones, Lab. Investig, 81, 735, 10.1038/labinvest.3780282

Boettger-Tong, 1998, A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens, Environ. Health Perspect, 106, 369, 10.1289/ehp.98106369

Axelson, 1981, The excretion of lignans in rats—evidence for an intestinal bacterial source for this new group of compounds, FEBS Lett, 123, 337, 10.1016/0014-5793(81)80322-5

Setchell, K.D.R., Zimmer-Nechemias, L., Cai, J. & Heubi, J. E. (1997) Exposure of infants to phyto-oestrogens from soy-based infant formula [see comments.]. Lancet 350:23–27.

Setchell, 1998, Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life, Am. J. Clin. Nutr, 68, 1453S, 10.1093/ajcn/68.6.1453S

Monfort, 1984, Identification of a non-steroidal estrogen, equol, in the urine of pregnant macaques: correlation with steroidal estrogen excretion, J. Steroid Biochem, 20, 869, 10.1016/0022-4731(84)90398-4

Adlercreutz, 1986, Identification of lignans and phytoestrogens in urine of chimpanzees, Clin. Chim. Acta, 158, 147, 10.1016/0009-8981(86)90230-5

Juniewicz, 1988, Identification of phytoestrogens in the urine of male dogs, J. Steroid Biochem, 31, 987, 10.1016/0022-4731(88)90343-3

Murphy, 1982, Phytoestrogen content of processed soybean products, Food Technol, 43, 60

Coward, 1993, Genistein and daidzein, and their β-glycosides conjugates: anti-tumor isoflavones in soybean foods from American and Asian diets, J. Agric. Food Chem, 41, 1961, 10.1021/jf00035a027

Setchell, 2001, Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements, J. Nutr, 131, 1362S, 10.1093/jn/131.4.1362S

Rong, 1998, Narrow-bore HPLC analysis of isoflavonoid aglycones and their O- and C-glycosides from Pueraria lobata, Biomed. Chromatogr, 12, 170, 10.1002/(SICI)1099-0801(199805/06)12:3<170::AID-BMC799>3.0.CO;2-M

Bannwart, C., Adlercreutz, H., Fotsis, T., Wähälä, K., Hase, T. & Brunow, G. (1984) Identification of O-desmethylangolensin, a metabolite of daidzein and of matairesinol, one likely plant precursor of the animal lignan enterolactone in human urine. Finn. Chem. Lett. 4–5:120–125.

Kelly, 1993, Metabolites of dietary (soya) isoflavones in human urine, Clin. Chim. Acta, 223, 9, 10.1016/0009-8981(93)90058-C

Joannou, 1995, A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids, J. Steroid Biochem. Mol. Biol, 54, 167, 10.1016/0960-0760(95)00131-I

Heinonen, 1999, Identification of isoflavone metabolites dihydrodaidzein, dihydrogenistein, 6′-OH-O-DMA, and cis-4-OH-equol in human urine by gas chromatography-mass spectroscopy using authentic reference compounds, Anal. Biochem, 274, 211, 10.1006/abio.1999.4279

Setchell, 2002, Evidence for lack of absorption of soy isofalvone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability, Am. J. Clin. Nutr, 76, 447, 10.1093/ajcn/76.2.447

Day, 1998, Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity, FEBS Lett, 436, 71, 10.1016/S0014-5793(98)01101-6

Zhang, 1999, Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity, J. Nutr, 129, 957, 10.1093/jn/129.5.957

Setchell, K.D.R., Faughnan, M. S., Avades, T., Zimmer-Nechemias, L., Brown, N. B., Wolfe, B., Brashear, W. T., Desai, P., Oldfield, M. F., Botting, N. P. & Cassidy, A. (2003) Comparing the pharmacokinetics of daidzein and genistein using [13C]labeled tracers in premenopausal women. Am. J. Clin. Nutr. (in press).

Adlercreutz, 1993, Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry, Scand. J. Clin. Lab. Investig. Suppl, 215, 5, 10.3109/00365519309090693

Doerge, 2000, Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry, Drug Metab. Dispos, 28, 298

Sfakianos, 1997, Intestinal uptake and biliary excretion of the isoflavone genistein in rats, J. Nutr, 127, 1260, 10.1093/jn/127.7.1260

Andlauer, 2000, Absorption and metabolism of genistein in isolated rat small intestine, J. Nutr, 130, 843, 10.1093/jn/130.4.843

Kelly, 1995, The variable metabolic response to dietary isoflavones in humans, Proc. Soc. Exp. Biol. Med, 208, 40, 10.3181/00379727-208-43829

Karr, 1997, Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption, Am. J. Clin. Nutr, 66, 46, 10.1093/ajcn/66.1.46

Lampe, 1998, Urinary equol excretion with a soy challenge: influence of habitual diet, Proc. Soc. Exp. Biol. Med, 217, 335, 10.3181/00379727-217-44241

Rowland, 2000, Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut flora, Nutr. Cancer, 36, 27, 10.1207/S15327914NC3601_5

Cassidy, A. (1991) Plant Oestrogens and Their Relation to Hormonal Status in Women. Doctoral thesis, University of Cambridge, Cambridge, UK.

Setchell, 1999, Dietary isoflavones: biological effects and relevance to human health, J. Nutr, 129, 758S, 10.1093/jn/129.3.758S

Lampe, 2001, Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavone equol in premenopausal women, J. Nutr, 131, 740, 10.1093/jn/131.3.740

Setchell, 1983, Measurement of enterolactone and enterodiol, the first mammalian lignans using stable isotope dilution and gas chromatography-mass spectrometry, Biomed. Mass Spectrom, 10, 227, 10.1002/bms.1200100321

Setchell, 1981, Lignan formation in man—microbial involvement and possible roles in relation to cancer, Lancet, 2, 4, 10.1016/S0140-6736(81)90250-6

Uehara, 2001, Dietary fructopolysaccharides modify intestinal bioavailability of a single dose of genistein and daidzein and affect their urinary excretion and kinetics in blood of rats, J. Nutr, 131, 787, 10.1093/jn/131.3.787

Ueno, T. & Uchiyama, S. (2001) Identification of the specific intestinal bacteria capable of metabolising soy isoflavone to equol. Ann. Nutr. Metab. 45:114 (abs.).

Kuiper, 1996, Cloning of a novel receptor expressed in rat prostate and ovary, Proc. Natl. Acad. Sci. U.S.A, 93, 5925, 10.1073/pnas.93.12.5925

Kuiper, 1997, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta, Endocrinology, 138, 863, 10.1210/endo.138.3.4979

Kuiper, 1998, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta, Endocrinology, 139, 4252, 10.1210/endo.139.10.6216

Morito, 2001, Interaction of phytoestrogens with estrogen receptors α and β, Biol. Pharm. Bull, 24, 351, 10.1248/bpb.24.351

Nagel, 1998, The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity, Proc. Soc. Exp. Biol. Med, 217, 300, 10.3181/00379727-217-44236

Martin, 1996, Interactions between phytoestrogens and human sex steroid binding protein, Life Sci, 58, 429, 10.1016/0024-3205(95)02308-9

Garreau, B., Vallette, G., Adlercreutz, H., Wähälä, K., Makela, T., Benassayag, C. & Nunez, E. A. (1991) Phytoestrogens: new ligands for rat and human alpha-fetoprotein [published erratum appears in Biochim. Biophys. Acta 1133: 113]. Biochim. Biophys. Acta 1094:339–345.

Hodgson, 1996, Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum, J. Nutr. Biochem, 7, 664, 10.1016/S0955-2863(96)00133-7

Mitchell, 1998, Antioxidant efficacy of phytoestrogens in chemical and biological model systems, Arch. Biochem. Biophys, 360, 142, 10.1006/abbi.1998.0951

Arora, 1998, Antioxidant activities of isoflavones and their biological metabolites in a liposomal system, Arch. Biochem. Biophys, 356, 133, 10.1006/abbi.1998.0783

Hodgson, 1999, Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure, Atherosclerosis, 145, 167, 10.1016/S0021-9150(99)00029-5

Tikkanen, 1998, Effect of soybean phytoestrogen intake on low density lipoprotein (LDL) oxidation resistance, Proc. Natl. Acad. Sci. U.S.A, 95, 3106, 10.1073/pnas.95.6.3106

Scheiber, 1999, Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy?, Menopause, 6, 233, 10.1097/00042192-199906030-00010

Jenkins, 2000, Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity—a controlled crossover trial, Metabolism, 49, 537, 10.1016/S0026-0495(00)80022-0

Wiseman, 2000, Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans, Am. J. Clin. Nutr, 72, 395, 10.1093/ajcn/72.2.395

Akiyama, 1987, Genistein, a specific inhibitor of tyrosine-specific protein kinases, J. Biol. Chem, 262, 5592, 10.1016/S0021-9258(18)45614-1

Kim, 1998, Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways, Am. J. Clin. Nutr, 68, 1418S, 10.1093/ajcn/68.6.1418S

Lapcik, 1997, A novel radioimmunoassay for daidzein, Steroids, 62, 315, 10.1016/S0039-128X(96)00226-7

Lapcik, 1998, Radioimmunoassay of free genistein in human serum, J. Steroid Biochem. Mol. Biol, 64, 261, 10.1016/S0960-0760(97)00199-4

Kohen, 1998, The measurement of the isoflavone daidzein by time resolved fluorescent immunoassay: a method for assessment of dietary soy exposure, J. Steroid Biochem. Mol. Biol, 64, 217, 10.1016/S0960-0760(97)00156-8

Uehara, 1999, Rapid analysis of phytoestrogens in human urine by time-resolved fluoroimmunoassay, J. Steroid Biochem. Mol. Biol, 72, 273, 10.1016/S0960-0760(00)00045-5

Barkley, 1985, Equol: a contributor to enigmatic immunoassay measurements of estrogen, Steroids, 46, 587, 10.1016/0039-128X(85)90024-8

Cassidy, A., Bingham, S. & Setchell, K.D.R. (1994) Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women [see comments]. Am. J. Clin. Nutr. 60:333–340.

Cassidy, 1995, Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products, Br. J. Nutr, 74, 587, 10.1079/BJN19950160

The North American Menopause Society (2000) The role of isoflavones in menopausal health: consensus opinion of the North American Menopause Society. Menopause 7:215–229.

Wilcox, 1990, Oestrogenic effects of plant foods in postmenopausal women, Br. Med. J, 301, 905, 10.1136/bmj.301.6757.905-a

Murkies, 1995, Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat, Maturitas, 21, 189, 10.1016/0378-5122(95)00899-V

Brzezinski, 1997, Short-term effects of phytoestrogen-rich diet on postmenopausal women, Menopause, 4, 89, 10.1097/00042192-199704020-00005

Albertazzi, 1998, The effect of dietary soy supplementation on hot flushes, Obstet. Gynecol, 91, 6, 10.1016/S0029-7844(97)00597-8

Washburn, S., Burke, G. L., Morgan, T. & Anthony, M. (1999) Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women [see comments]. Menopause 6:7–13.

Dalais, 1998, Effects of dietary phytoestrogens in postmenopausal women, Climacteric, 1, 124, 10.3109/13697139809085527

Nachtigall, L., Fenichel, R., La Grega Lee, W. & Nachtigall, L. (1999) The effects of isoflavone derived from red clover on vasomotor symptoms, endometrial thickness, and reproductive hormone concentrations in menopausal women (abs.). Presented at the 81st Annual Meeting of the Endocrine Society, San Diego, CA.

Baber, 1999, Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women, Climacteric, 2, 85, 10.3109/13697139909025571

Knight, 1999, The effect of Promensil, an isoflavone extract on menopausal symptoms, Climacteric, 2, 79, 10.3109/13697139909025570

Albertazzi, 1999, Dietary soy supplementation and phytoestrogen levels, Obstet. Gynecol, 94, 229

Upmalis, 2000, Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study, Menopause, 7, 236, 10.1097/00042192-200007040-00005

Scambia, 2000, Clinical effects of a standardized soy extract in postmenopausal women: a pilot study, Menopause, 7, 105, 10.1097/00042192-200007020-00006

Quella, 2000, Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central cancer treatment group trial, J. Clin. Oncol, 18, 1068, 10.1200/JCO.2000.18.5.1068

St.Germain, 2001, Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment, Menopause, 8, 17, 10.1097/00042192-200101000-00005

Nagata, 2001, Soy product intake and hot flashes in Japanese women: Results from a community-based prospective study, Am. J. Epidemiol, 153, 790, 10.1093/aje/153.8.790

Uchiyama, S., Ueno, T. & Shirota, T. (2001) The relationship between soy isoflavones and the menopausal symptoms in Japanese perimenopausal women. Ann. Nutr. Metab. 45:113 (abs.).

Erdman, 2000, Provocative relation between soy and bone maintenance, Am. J. Clin. Nutr, 72, 679, 10.1093/ajcn/72.3.679

Blair, 1996, Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats, J. Cell Biochem, 61, 629, 10.1002/(SICI)1097-4644(19960616)61:4<629::AID-JCB17>3.0.CO;2-A

Anderson, 1997, The effects of phytoestrogens on bone, Nutr. Res, 20, 220

Williams, 1998, Tyrosine kinase inhibitor effects on avian osteoclastic acid transport, Am. J. Clin. Nutr, 68, 1369S, 10.1093/ajcn/68.6.1369S

Yamaguchi, 2000, Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: activation of aminoacyl-t-RNA synthetase, Mol. Cell. Biochem, 214, 97, 10.1023/A:1007199120295

Viereck, 2002, Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts, J. Cell. Biochem, 84, 725, 10.1002/jcb.10087

Arjmandi, 1996, Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis, J. Nutr, 126, 161, 10.1093/jn/126.1.161

Draper, 1997, Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats, J. Nutr, 127, 1795, 10.1093/jn/127.9.1795

Anderson, 1998, Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model, Proc. Soc. Exp. Biol. Med, 217, 345, 10.3181/00379727-217-44243

Ishida, 1998, Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet, Biol. Pharm. Bull, 21, 62, 10.1248/bpb.21.62

Alexanderson, 2001, Ipriflavone in the treatment of postmenopausal osteoporosis. A randomized controlled trial, J. Am. Med. Assoc, 285, 1482, 10.1001/jama.285.11.1482

Pansini, F., Bonaccorsi, G., Albertazzi, P., Costantino, D., Valerio, A., Negri, C., Ferrazzini, S., Bonocuore, I., De Aloysio, D., Fontana, A., Pansini, N. & Mollica, G. (1997) Soy phytoestrogens and bone. Proceedings of the North American Menopause Society, p. 44 (abs.).

Horiuchi, 2000, Effect of soy protein on bone metabolism in postmenopausal women, Osteoporosis, 11, 721, 10.1007/s001980070072

Mei, 2001, High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women, J. Clin. Endocrinol. Metab, 86, 5217, 10.1210/jcem.86.11.8040

Scheiber, 2001, Dietary inclusion of whole soy foods results in significant reductions in clinical risk for osteoporosis and cardiovascular disease in normal postmenopausal women, Menopause, 8, 384, 10.1097/00042192-200109000-00015

Alekel, 2000, Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women, Am. J. Clin. Nutr, 72, 844, 10.1093/ajcn/72.3.844

Gallagher, J. C., Rafferty, K., Haynatzka, V. & Wilson, M. (2000) The effect of soy protein on bone metabolism. J. Nutr. 130:667S (abs.).

Potter, 1998, Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women, Am. J. Clin. Nutr, 68, 1375S, 10.1093/ajcn/68.6.1375S

Lydeking-Olsen, E., Jensen, J.-B.E., Setchell, K.D.R., Damhus, M. & Jensen, T. H. (2002) Isoflavone-rich soymilk prevents bone-loss in the lumbar spine of postmenopausal women. A 2 year study. J. Nutr. 132:581S (abs.).

Lydeking-Olsen, E., Meinertz, H., Nilausen, K., Setchell, K.D.R., Damhus, M. & Jensen, T. H. (2002) Lipoprotein effects of soy milk and progesterone for prevention of bone loss in post menopausal hypercholesterolemic women. J. Nutr. 132:608S (abs.).

Anderson, 1995, Meta-analysis of the effects of soy protein intake on serum lipids [see comments], N. Engl. J. Med, 333, 276, 10.1056/NEJM199508033330502

Merz-Demlow, 1999, Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women, Am. J. Clin. Nutr, 71, 1462, 10.1093/ajcn/71.6.1462

Wangen, 2000, Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women, Am. J. Clin. Nutr, 73, 225, 10.1093/ajcn/73.2.225